F007

· Shandong New Time Pharmaceutical Co., LTD

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for F007, covering 2022-01-05 to 2022-01-05. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study to Evaluate the Efficacy and Safety of F520 Combined With F007 in Patients With RR DLBCL [Phase 2]

See pricing